Debt-to-equity of Werewolf Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Werewolf Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Werewolf Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 101%, a 91% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Werewolf Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 101% +48% +91% 30 Sep 2025
Q2 2025 78% +25% +47% 30 Jun 2025
Q1 2025 63% +8% +14% 31 Mar 2025
Q4 2024 56% -2% -3.8% 31 Dec 2024
Q3 2024 53% +2% +3.7% 30 Sep 2024
Q2 2024 53% +9% +19% 30 Jun 2024
Q1 2024 55% +16% +40% 31 Mar 2024
Q4 2023 58% +29% +101% 31 Dec 2023
Q3 2023 51% +26% +104% 30 Sep 2023
Q2 2023 45% +27% +148% 30 Jun 2023
Q1 2023 39% +29% +264% 31 Mar 2023
Q4 2022 29% +14% +95% 31 Dec 2022
Q3 2022 25% +3% +13% 30 Sep 2022
Q2 2022 18% 30 Jun 2022
Q1 2022 11% 31 Mar 2022
Q4 2021 15% 31 Dec 2021
Q3 2021 22% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.